We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
A reason or two:
They’ve got $1bn in cash.
P/E ratio of less than 2:1.
YTD Adj. Net Income 4% better than Q3-2018 ($248m) despite -15% Net Income reduction.
Guys, I fully understand your frustration, I have been in this same situation on three occasions with this share and each time I sold for a very small profit and then regretted it. My view on this share now is to ignore the price fluctuations and wait for the court result. I don't think Indivior is going to get a big fine and the share price will then rebound significantly higher than current price. This is just my opinion and I wish you all the very best with whatever you decide, however, I will definitely be holding this one waiting for good positive news. Bearing in mind all these MM's shenanigans will continue until hopefully positive news is released, this could continue until May 2020. However, a settlement could easily be reached way before this date.
GLA
Dog of a share, falls nearly 7%., on what news? next to none!
Worst performing share in my books , may just swallow the losses on this one , the sacking of the counsel , the refused disclosure requests, the multiple million potentially billion fine looming, the competition stepping up....anyone got any positives atm ?
Drop in price possibly coincided with mid-day auction.
GLA
Possibly a TR-1 soon showing a decrease in holdings.....hopefully not.
GLA
The regular big movements with this share for absolutely no reason is par for the course. I thought there was an issue this morning with the reported trades on LSE, however, it simply looks like no one was trading the share for a significant period. MM's continue to manipulate . We need good positive news. In fact I would not be surprised if we finish blue today.......but please don't quote me on that :-)
GLA
GLA
Looks like your enthusiasm bubble has burst:(
Down down again... What a s**t of a share!
Indivior Launches National Campaign Informing People of an Additional Treatment for Opioid Use Disorder (OUD) and to Let Peop...
11/11/2019 5:43pm
PR Newswire (US)
Indivior (LSE:INDV)
Intraday Stock Chart
Today : Monday 11 November 2019
Click Here for more Indivior Charts.
RICHMOND, Va., Nov. 11, 2019 /PRNewswire/ -- Indivior PLC (LON: INDV) announces the launch of a new direct-to-consumer (DTC) advertising campaign, Keep Moving Towards Recovery, which aims to heighten awareness of treatment with SUBLOCADE® (buprenorphine extended-release) injection, for subcutaneous use (CIII), as well as motivate those with moderate to severe opioid use disorder (OUD) and those who care about them to seek help from health care professionals to keep moving towards recovery. SUBLOCADE is a prescription medicine used to treat adults with moderate to severe addiction (dependence) to opioid drugs (prescription or illegal) who have received an oral transmucosal (used under the tongue or inside the cheek) buprenorphine-containing medicine at a dose that controls withdrawal symptoms for at least 7 days. SUBLOCADE is part of a complete treatment plan that should include counseling.1
The Keep Moving Towards Recovery campaign is intended to help reframe the perceptions of those struggling with moderate to severe opioid addiction. Opioid addiction isn't a moral weakness, it is a chronic disease called Opioid Use Disorder (OUD)2 in which people develop a pattern of using opioids that can lead to negative consequences.3 OUD may affect the parts of the brain that control impulses, judgment, and decision-making.3,4 Patients become trapped in a cycle of opioid use, withdrawal, and cravings, which produces changes in brain function that can reduce their ability to control their use.3,5
"Although the medical community has recognized that opioid addiction is a chronic disease, many people with OUD are still not receiving appropriate, evidence-based therapies," said Gary Mendell, Founder and CEO of Shatterproof. "Closing this gap and ensuring that people impacted have access to the combination of counseling and medication for the addiction treatment that is best for them is critical to reversing the tragic trends across the country."
Medication-assisted treatment (MAT) combines medication and counseling to treat both the physical and behavioral parts of opioid addiction, with the goal of helping people achieve and maintain recovery.3,4 The combination of medicine and psychosocial therapy have been proven successful in treating OUD and can even help extend recovery.3,4 In fact, MAT has been shown to be more effective than either medication or counseling alone.4
"While the Keep Moving Towards Recovery DTC campaign is anticipated to help raise awareness of treatment with SUBLOCADE, we also hope this campaign will contribute to the broader effort underway to help people suffering from OUD to know that medication, including counseling, is available to help them tr
I call it slow rather than steady... still swinging around... but in the right direction which is good!
steady and slow....that's how I like it!